sinonasal lymphoma presenting as a probable sanctuary site for relapsed b acute lymphoblastic leukaemia: a case report and review of the literature

Clicks: 151
ID: 255266
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #39 of 57 articles by views in Turkish journal of haematology : official journal of Turkish Society of Haematology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Sinonasal lymphoma is a non-Hodgkin lymphoma (NHL) representing 1.5% of all lymphomas. It presents as an unremitting ulceration with progressive destruction of midline sinonasal and surrounding structures. Poor prognosis warrants early treatment although diagnosis is challenging and frequently delayed. It is usually primary in origin and to our knowledge the sinonasal region has never been reported as a sanctuary site in leukaemia/lymphoma relapse. We present a unique case of B-cell ALL (acute lymphoblastic leukaemia) with late relapse to the nasal septum as a sinonasal lymphoblastic lymphoma and with genetic support for this as a sanctuary site.
Reference Key
lim2015casesinonasal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;W. Y. Lim;R. Care;M. Lau;S. Chiruka;P. J. D. Dawes
Journal Turkish journal of haematology : official journal of Turkish Society of Haematology
Year 2015
DOI
10.1155/2015/697957
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.